Trials / Not Yet Recruiting
Not Yet RecruitingNCT06977399
The Application Value of Spectral CT in the Accurate Staging of Liver Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Yunnan Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Spectral CT was used to prospectively collect medical images and clinical data related to liver cancer, evaluate the effect of image quality in the diagnosis of liver cancer, and evaluate the application value in the accurate staging of liver cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | To explore the value of spectral CT in the diagnosis and treatment of liver cancer | The CT scan is part of the standard treatment protocol. |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-05-31
- Completion
- 2026-05-31
- First posted
- 2025-05-18
- Last updated
- 2025-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06977399. Inclusion in this directory is not an endorsement.